NAYA (NAYA Biosciences) Kacepetan wutah bathi saben saham ing taun lumaku
The annual EPS volatility reflects profit dynamics, where 92.70 indicates the current value of the metric. The financial profile of NAYA Biosciences (NAYA) is constrained by R&D expenses but protected by antibody patents. Its status as a scientific leader reinforces investor confidence in the development of multispecific proteins. The company's technologies are based on training the immune system to accurately recognize tumors, which helps combat aggressive forms of cancer.
Rincian metrik keuangan lan pasar nayabiosciences.com (NAYA)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Utang marang Modal NAYA Biosciences|NAYA - Utang jangka dawa marang modal|Utang jangka cendhak marang modal NAYA Bio|NAYA - Gunggung utang perusahaan|Rasio utang marang aset resik NAYA Biosciences|NAYA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan NAYA Biosciences|Koefisien jangkoan perantara nayabiosciences.com
- statistik bathi lan rasio pasar:
NAYA - Bathi resik perusahaan|Bathi resik sing dikarepake NAYA Biosciences|NAYA - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi NAYA Biosciences|NAYA - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NAYA Biosciences|NAYA - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan NAYA Biosciences|NAYA - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan nayabiosciences.com|NAYA - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep NAYA Biosciences
- informasi babagan volume dodolan lan pendapatan:
Ringkesan analisis perusahaan:NAYA Bio (NAYA)
Institutional capital assesses the attractiveness of NAYA Biosciences (NAYA) through the dynamics of profit generation efficiency. This relative annual growth in net income per share measures the percentage deviation of the current EPS from the value of the same period last year, revealing hidden profitability trends. The stability of this metric confirms the asset's reliability, reflecting financial resilience in organizing complex biomaterial logistics for oncology research.
Pesaing langsung
Kacepetan wutah bathi saben saham ing taun lumaku BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku revmed.com RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi resik saben saham ing taun iki CG Oncology CGON|Wutah bathi saben saham ing taun lumaku UroGen URGN|Prakiraan wutah bathi resik saben saham ing taun iki Bicara Bio (BCAX)|PSNL - Wutah bathi saben saham ing taun lumaku|ERAS - Wutah bathi ing taun lumaku|DCTH: Wutah bathi ing taun lumaku|Y-mAbs Therapeutics, Inc. (YMAB) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki AURA|Kacepetan wutah bathi saben saham ing taun lumaku candeltx.com CADL|Wutah bathi ing taun lumaku ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ACTU (Actuate Therapeutics Inc)|Tambahing bathi saben saham ing taun lumaku CTOR|tuhurabio.com - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Wutah bathi saben saham ing taun lumaku|WHWK - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku tscan.com|CSBR: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku XBiotech USA (XBIT)|CVM: Dinamika bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku ostherapies.com OSTX|Wutah bathi resik saben siji saham kanggo taun lumaku RADX (Radiopharm Theranostics Limited)|Artiva - Wutah bathi ing taun lumaku|ANL: Wutah bathi saben saham ing taun lumaku|VERU: Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku renovarobio.com RENB|Wutah bathi saben saham ing taun lumaku muraloncology.com (MURA)|Wutah bathi resik saben siji saham kanggo taun lumaku KAPA|Wutah bathi ing taun lumaku OKUR (onkuretherapeutics.com)|Wutah bathi resik saben siji saham kanggo taun lumaku GDTC (CytoMed)|Curis - Wutah bathi ing taun lumaku|APLM: Wutah bathi saben saham ing taun lumaku|Tharimmune (THAR) - Wutah bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki Advanced Biomed Inc.|GNPX (Genprex Inc) - Wutah bathi ing taun lumaku|Calidi Biotherapeutics (CLDI) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku SBFM|Wutah bathi saben saham ing taun lumaku XBIO (Xenetic Biosciences, Inc.)|Wutah bathi ing taun lumaku SLRX (salariuspharma.com)|PPBT - Wutah bathi resik saben saham ing taun iki|AONC - Wutah bathi saben saham ing taun lumaku|Tambahing bathi saben saham ing taun lumaku BGNE (BeOne Medicines)|CKPT: Wutah bathi ing taun lumaku|Elevation Oncology Inc. (ELEV) - Wutah bathi ing taun lumaku|ICAD (iCAD) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku ikenaoncology.com|Wutah bathi ing taun lumaku NTBL|Wutah bathi ing taun lumaku Viracta Therapeutics Inc. (VIRX)|Wutah bathi saben saham ing taun lumaku MorphoSys Inc MOR|Owah-owahan bathi resik saben saham ing taun lumaku Ascentage Pharma
